Showing results (1-10 of 77) with videos related to
Sort By:
Pageof 8
Translational Lung Cancer Research|December 3, 2015
Revisiting the role of COX-2 inhibitor for non-small cell lung cancerHiroshi Yokouchi, Kenya KanazawaJournal of Cancer Research and Therapeutics|September 26, 2018
Renin-producing germ cell tumor in the pineal apparatus and mediastinum: A rare case reportManabu Uematsu, Hiroshi Yokouchi, Yoshinori Tanino, et al.Human Immunology|November 24, 2004
The characteristics of human NKT cells in lung cancer--CD1d independent cytotoxicity against lung cancer cells by NKT cells and decreased human NKT cell response in lung cancer patientsJun Konishi, Koichi Yamazaki, Hiroshi Yokouchi, et al.Journal of Diabetes and Its Complications|August 30, 2002
Elevated serum KL-6 concentrations in patients with diabetes mellitusToru Takahashi, Kei Takamura, Sinji Sakaue, et al.Journal of Thoracic Disease|October 29, 2019
Patient outcomes post-pulmonary resection for synchronous bone-metastatic non-small cell lung cancerYuki Takahashi, Hirofumi Adachi, Yasushi Mizukami, et al.Lung Cancer (Amsterdam, Netherlands)|October 19, 2006
Non-responsiveness to gefitinib in a patient with lung adenocarcinoma having rare EGFR mutations S768I and V769LHajime Asahina, Koichi Yamazaki, Ichiro Kinoshita, et al.Respiratory Medicine Case Reports|May 6, 2026
Leptomeningeal metastatic disease responding to carboplatin, pemetrexed, and amivantamab after progression to osimertinib in EGFR exon 21 L858R-Mutated non-small cell lung cancer: Two case reportsRyohei Kamada, Hajime Asahina, Hidenori Mizugaki, et al.Internal Medicine (Tokyo, Japan)|December 12, 2017
The Effectiveness of Afatinib in a Patient with Advanced Lung Adenocarcinoma Harboring Rare G719X and S768I MutationsMasahiro Watanabe, Satoshi Oizumi, Shizuka Kiuchi, et al.International Journal of Clinical Oncology|April 25, 2009
Phase I study of amrubicin and vinorelbine in non-small cell lung cancer previously treated with platinum-based chemotherapySatoshi Oizumi, Koichi Yamazaki, Hiroshi Yokouchi, et al.Cancer Immunology, Immunotherapy : CII|July 14, 2007
Immunotherapy with dendritic cells pulsed with tumor-derived gp96 against murine lung cancer is effective through immune response of CD8+ cytotoxic T lymphocytes and natural killer cellsNaofumi Shinagawa, Koichi Yamazaki, Yasuaki Tamura, et al.Pageof 8